Kwmg LLC Acquires 15,433 Shares of Bath & Body Works, Inc. $BBWI

Key Points

• Kwmg LLC increased its holdings in Bath & Body Works by 10.6%, acquiring 15,433 shares, bringing its total to 160,405 shares valued at approximately $4.8 million.
• Several institutional investors significantly increased their stakes in Bath & Body Works, with Victory Capital Management raising its position by 14,732% to own nearly 6.8 million shares.
• Analysts have issued mixed ratings, with JPMorgan raising its target price to $46, while others like Morgan Stanley lowered theirs to $18, indicating differing outlooks on the company's performance.

Kwmg LLC boosted its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 10.6% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 160,405 shares of the company's stock after acquiring an additional 15,433 shares during the quarter. Kwmg LLC owned approximately 0.08% of Bath & Body Works worth $4,806,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in BBWI. Victory Capital Management Inc. raised its position in Bath & Body Works by 14,732.0% during the first quarter. Victory Capital Management Inc. now owns 6,798,108 shares of the company's stock valued at $206,119,000 after acquiring an additional 6,752,274 shares in the last quarter. AQR Capital Management LLC raised its position in Bath & Body Works by 267.8% during the first quarter. AQR Capital Management LLC now owns 3,993,173 shares of the company's stock valued at $121,073,000 after acquiring an additional 2,907,506 shares in the last quarter. Fuller & Thaler Asset Management Inc. raised its position in Bath & Body Works by 115.7% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 3,680,104 shares of the company's stock valued at $111,581,000 after acquiring an additional 1,973,679 shares in the last quarter. Assenagon Asset Management S.A. raised its position in Bath & Body Works by 3,642.2% during the first quarter. Assenagon Asset Management S.A. now owns 1,651,109 shares of the company's stock valued at $50,062,000 after acquiring an additional 1,606,988 shares in the last quarter. Finally, T. Rowe Price Investment Management Inc. raised its position in shares of Bath & Body Works by 7.6% in the first quarter. T. Rowe Price Investment Management Inc. now owns 11,016,767 shares of the company's stock valued at $334,029,000 after purchasing an additional 781,681 shares during the period. Institutional investors own 95.14% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the stock. JPMorgan Chase & Co. raised their price objective on shares of Bath & Body Works from $40.00 to $46.00 and gave the stock an "overweight" rating in a research note on Monday, July 28th. Barclays boosted their target price on shares of Bath & Body Works from $30.00 to $32.00 and gave the company an "equal weight" rating in a research note on Friday, August 29th. Morgan Stanley reduced their target price on shares of Bath & Body Works from $19.00 to $18.00 and set an "overweight" rating on the stock in a research note on Friday, September 12th. Telsey Advisory Group restated an "outperform" rating and issued a $38.00 target price on shares of Bath & Body Works in a research note on Thursday, August 28th. Finally, The Goldman Sachs Group reduced their target price on shares of Bath & Body Works from $44.00 to $43.00 and set a "buy" rating on the stock in a research note on Friday, May 30th. Twelve research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $39.69.

Bath & Body Works Trading Up 3.2%

NYSE:BBWI opened at $25.88 on Tuesday. The firm has a fifty day simple moving average of $29.46 and a 200 day simple moving average of $29.69. Bath & Body Works, Inc. has a 1-year low of $24.93 and a 1-year high of $41.87. The stock has a market capitalization of $5.34 billion, a PE ratio of 7.68, a P/E/G ratio of 0.86 and a beta of 1.49.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its quarterly earnings results on Thursday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.37. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The business had revenue of $1.55 billion during the quarter, compared to the consensus estimate of $1.55 billion. During the same quarter last year, the firm posted $0.37 EPS. The company's quarterly revenue was down .8% on a year-over-year basis. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. On average, equities analysts predict that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, September 5th. Shareholders of record on Friday, August 22nd were issued a dividend of $0.20 per share. The ex-dividend date of this dividend was Friday, August 22nd. This represents a $0.80 annualized dividend and a yield of 3.1%. Bath & Body Works's dividend payout ratio (DPR) is currently 23.74%.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.